The CEO's email is eugene@nanoviricides.com . He's always been very prompt and responsive in replying to emails from shareholders. Email him and ask your structural questions.
If you're concerned about divulging your IP address in the email header, use an anonymous proxy service -- several free ones online. Just search "free anonymous email".
Additionally, answers to all of your questions are contained in the SEC filings. Check the fresh 10k first. Here's the SEC link to the directory of NanoViricides filings:
Give one of those a try! The answers to all your repeated questions can easily be found (except that you already know the answers, right, and this is just an exercise for you?)
> The Board is the tired and true way to protect and create shareholder value
Keeping the head count and all expenses absolutely as low as possible is this company's current way of maximizing shareholder value by minimizing the need for dilution in this period before initial revenues.
If this company were to do all the things you just suggested, you'd instead be bitchin' about burn rate. You want them to recruit and compensate a whole soccer team full of people!
Well, if you don't believe that Bloomberg is giving you the correct information, what I suggest is contacting NNVC for the correct information, and then notifying Bloomberg that they are posting misinformation.
Maybe you can get some of your subscription fees back, too!
INSIDERS ON BOARD OF DIRECTORS AT NANOVIRICIDES INC (NNVC) Anil Diwan Ph.D., Chairman and President, Age 51 Eugene Seymour, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer and Director, Age 69
Other Board Members on Board of Directors* Paul Marks Ph.D., NanoViricides, Inc. Age 83 Harmon Aronson Ph.D., NanoViricides, Inc. Age 67 Cy Stein M.D., Ph.D., Tokai Pharmaceuticals, Inc. Age 57 John Rossi Ph.D., Dicerna Pharmaceuticals, Inc. Age 63 Thomas Lentz MD, ReceptoPharm, Inc. Age -- Kazuo Tsubota MD PhD, NanoViricides, Inc. Age --
*Data is at least as current as the most recent Definitive Proxy.
The listing of their respective Board Relationships are also listed.